8-K/A
Current Report
Alaunos Therapeutics, Inc. Filed Acc 0000950170-24-084024
Shareholder rights changed · Bylaws or fiscal year change
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading tcrt-20240716.htm…